Hotel

UTime Limited Announces Ambitious AI Health Strategy and Strategic Collaboration

SHENZHEN,China,Aug. 21,2024-- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce its ambitious strategy for advancing AI-driven health solutions. Recogni

08-27 UTime Limited

China's First Approved KRAS G12C Inhibitor: Innovent Announces the Approval of Dupert® (Fulzerasib) by the National Medical Products Administration of China

SAN FRANCISCOand SUZHOU,China,Aug. 22,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high qua

08-27 Innovent Biologics

Unlock the Power of Direct Investment: How BAI Capital's Direct Approach Transforms the EB-5 Experience

HO CHI MINH CITY,Vietnam,Aug. 22,2024-- BAI Capital,a distinguished boutique real estate developer based in Miami,Florida,is expanding its footprint into Vietnam,significantly impacting the EB-5 marke

08-27 BAI CapitalBecome American Investor LLC

Zepp Health Corporation Reports Second Quarter 2024 Unaudited Financial Results

MILPITAS,Calif.,Aug. 22,2024-- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenues of US$40.6million;a basic and diluted net lossper share of US$

08-27 Zepp Health Corp.

Cloud Music Inc. Reports First Half 2024 Financial Results

HANGZHOU,China,Aug. 22,2024-- Cloud Music Inc. (HKEX: 9899,"NetEase Cloud Music" or the "Company"),a leading interactive music streaming service provider in China,today announced i

08-27 NetEase Cloud Music

LYB to Acquire APK AG Recycling Technology

Expands Company\'s Technology Portfolio and Circular Hub Acquisition increasesLYB Circular and Low Carbon Solutions Business and diversification of innovative recycling technologies

08-27 LyondellBasell

YolTech Therapeutics Administers First Patient Dose in IIT of YOLT-203, the World's First In Vivo Gene Editing Therapy for PH1

SHANGHAI,Aug. 22,2024--YolTech Therapeutics,a pioneering clinical-stage gene editing company dedicated to delivering lifelong cures,today announced a major milestone: the first patient has been dosed

08-27 YolTech Therapeutics

Zhihu Inc. Reports Unaudited Second Quarter 2024 Financial Results

BEIJING,Aug. 23,2024-- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH; HKEX: 2390),a leading online content community in China,today announced its unaudited financial results for

08-27 Zhihu Inc.

Corina Intrauterine Drug-Eluting System approved in China as a novel treatment for patients with moderate-to-severe intrauterine adhesions (IUA)

The World\'s First-in-Class Intrauterine Drug-Eluting System SHANGHAI,Aug. 23,2024-- Corina Intrauterine Drug-Eluting System("Corina"), developed by Yipurun (Shanghai) Biotechnology Co.,Ltd

08-27 Puyi (Shanghai) Biotechnology Co., Ltd

Yunji Announces Second Quarter 2024 Unaudited Financial Results

HANGZHOU,China,Aug. 23,2024-- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ),a leading membership-based social e-commerce platform,today announced its unaudited financial resul

08-27 Yunji Inc.